Blood test can detect more than 50 types of cancer
Findings of the latest study assessing the test back its use as a screening tool, researchers say
Read More
Author: Selina McKee
Sanofi, Regeneron’s Libtayo cleared for basal cell carcinoma
Libtayo is the first immunotherapy indicated for patients with advanced basal cell carcinoma
Read More
Patient Partnership Index 2021 – results announced!
Three Gold Standards awarded for partnership work in patient advocacy and communications
Read More
£3m worth of illegally sold meds and devices seized in UK
Under Operation Pangea, officers were also able to shut down or block 113,000 illegally operating websites
Read More
Amicus’ Pompe disease therapy joins early access scheme
The MHRA has issued an EAMS scientific opinion opening the door to use of cipaglucosidase alfa with miglustat in eligible patients with Pompe disease
Read More- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
- Oregon and Lantern collaborate to develop drug candidate for various cancer indications
- OneChain’s CAR T trial treats its first cortical T-cell ALL patient
- Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
